386 related articles for article (PubMed ID: 25601687)
1. New potential biomarkers for mesterolone misuse in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry.
Lu J; Fernández-Álvarez M; Yang S; He G; Xu Y; Aguilera R
J Mass Spectrom; 2015 Jan; 50(1):153-9. PubMed ID: 25601687
[TBL] [Abstract][Full Text] [Related]
2. New clostebol metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometry and their application for doping control.
Lu J; Fernández-Álvarez M; Yang S; He G; Xu Y; Aguilera R
J Mass Spectrom; 2015 Jan; 50(1):191-7. PubMed ID: 25601692
[TBL] [Abstract][Full Text] [Related]
3. New drostanolone metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometry and their application for doping control.
Liu Y; Lu J; Yang S; Zhang Q; Xu Y
Steroids; 2016 Apr; 108():61-7. PubMed ID: 26826321
[TBL] [Abstract][Full Text] [Related]
4. New long term metabolite in human urine for metenolone misuse by liquid chromatography quadrupole time-of-flight mass spectrometry.
He G; Yang S; Lu J; Xu Y
Steroids; 2016 Jan; 105():1-11. PubMed ID: 26519767
[TBL] [Abstract][Full Text] [Related]
5. New Potential Biomarker for Methasterone Misuse in Human Urine by Liquid Chromatography Quadrupole Time of Flight Mass Spectrometry.
Zhang J; Lu J; Wu Y; Wang X; Xu Y; Zhang Y; Wang Y
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669235
[TBL] [Abstract][Full Text] [Related]
6. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS.
Fragkaki AG; Angelis YS; Kiousi P; Georgakopoulos CG; Lyris E
J Mass Spectrom; 2015 May; 50(5):740-8. PubMed ID: 26259657
[TBL] [Abstract][Full Text] [Related]
7. Metabolic studies of mesterolone in horses.
Ho EN; Leung DK; Leung GN; Wan TS; Wong HN; Xu X; Yeung JH
Anal Chim Acta; 2007 Jul; 596(1):149-55. PubMed ID: 17616252
[TBL] [Abstract][Full Text] [Related]
8. Markers of mesterolone abuse in sulfate fraction for doping control in human urine.
Kiousi P; Angelis YS; Fragkaki AG; Abushareeda W; Alsayrafi M; Georgakopoulos C; Lyris E
J Mass Spectrom; 2015 Dec; 50(12):1409-19. PubMed ID: 26634976
[TBL] [Abstract][Full Text] [Related]
9. Structural elucidation of new urinary tamoxifen metabolites by liquid chromatography quadrupole time-of-flight mass spectrometry.
Lu J; He C; He G; Wang X; Xu Y; Wu Y; Dong Y; Ouyang G
J Mass Spectrom; 2014 Jul; 49(7):570-8. PubMed ID: 25044841
[TBL] [Abstract][Full Text] [Related]
10. Analysis of anabolic androgenic steroids as sulfate conjugates using high performance liquid chromatography coupled to tandem mass spectrometry.
Rzeppa S; Heinrich G; Hemmersbach P
Drug Test Anal; 2015; 7(11-12):1030-9. PubMed ID: 26472592
[TBL] [Abstract][Full Text] [Related]
11. Alternative long-term markers for the detection of methyltestosterone misuse.
Gómez C; Pozo OJ; Marcos J; Segura J; Ventura R
Steroids; 2013 Jan; 78(1):44-52. PubMed ID: 23127819
[TBL] [Abstract][Full Text] [Related]
12. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
[TBL] [Abstract][Full Text] [Related]
13. Urinary detection of conjugated and unconjugated anabolic steroids by dilute-and-shoot liquid chromatography-high resolution mass spectrometry.
Tudela E; Deventer K; Geldof L; Van Eenoo P
Drug Test Anal; 2015 Feb; 7(2):95-108. PubMed ID: 24753397
[TBL] [Abstract][Full Text] [Related]
14. Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes.
Kiousi P; Fragkaki AG; Kioukia-Fougia N; Angelis YS
Drug Test Anal; 2021 Nov; 13(11-12):1822-1834. PubMed ID: 33942526
[TBL] [Abstract][Full Text] [Related]
15. LC-MS/(MS) confirmatory doping control analysis of intact phase II metabolites of methenolone and mesterolone after Girard's Reagent T derivatization.
Angelis YS; Fragkaki AG; Kiousi P; Sakellariou P; Christophoridis C
Drug Test Anal; 2023 Jun; 15(6):654-667. PubMed ID: 36843443
[TBL] [Abstract][Full Text] [Related]
16. New potential markers for the detection of boldenone misuse.
Gómez C; Pozo OJ; Geyer H; Marcos J; Thevis M; Schänzer W; Segura J; Ventura R
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):239-46. PubMed ID: 22664392
[TBL] [Abstract][Full Text] [Related]
17. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing.
Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M
Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860
[TBL] [Abstract][Full Text] [Related]
18. LC-MS/MS detection of unaltered glucuronoconjugated metabolites of metandienone.
Esquivel A; Pozo OJ; Garrostas L; Balcells G; Gómez C; Kotronoulas A; Joglar J; Ventura R
Drug Test Anal; 2017 Apr; 9(4):534-544. PubMed ID: 27237125
[TBL] [Abstract][Full Text] [Related]
19. Gas chromatography-mass spectrometry analysis of non-hydrolyzed sulfated steroids by degradation product formation.
Polet M; Van Gansbeke W; Albertsdóttir AD; Coppieters G; Deventer K; Van Eenoo P
Drug Test Anal; 2019 Nov; 11(11-12):1656-1665. PubMed ID: 31009554
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of novel long-term metabolites of oxymesterone and mesterolone in human urine by application of selected reaction monitoring GC-CI-MS/MS.
Polet M; Van Gansbeke W; Geldof L; Deventer K; Van Eenoo P
Drug Test Anal; 2017 Nov; 9(11-12):1673-1684. PubMed ID: 28296258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
